ArticleJournal of Cancer2018

Feasibility of continuing crizotinib therapy after RECIST-PD in advanced non-small cell lung cancer patients with

Jun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.